The A-share innovative drug sector continued to decline in the morning session, with Tonghua Jinma hitting the daily limit down, Jichuan Pharmaceutical approaching the daily limit down, and Yue Wannianqing, Lu Kang Pharmaceutical, Boteng Pharmaceutical, and Ruizhi Pharmaceutical following suit.